Royalty Pharma Income Statement (2019-2025) | RPRX

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 434.88M464.28M457.49M500.88M510.93M538.40M572.14M573.03M554.96M585.77M575.70M562.05M535.96M573.46M565.75M683.97M538.20M536.31M596.07M567.98M537.27M564.69M593.64M568.25M578.66M609.29M
Operating items
Amortization - Intangibles 6.60M5.80M5.80M5.73M5.73M5.80M5.80M5.67M5.73M5.80M5.80M5.67M
Research & Development 22.95M22.72M15.84M7.64M5.78M5.10M7.79M2.64M3.12M90.50M103.80M100.50M0.61M25.50M50.50M0.50M0.50M50.50M0.50M0.50M0.50M0.50M0.50M50.50M300.50M50.50M
Selling, General & Administrative 24.43M25.60M23.06M38.06M42.80M50.73M50.12M43.16M44.92M48.59M46.16M51.54M51.84M50.69M73.23M85.69M47.63M57.23M59.19M57.65M54.71M56.72M67.59M110.70M179.77M118.73M
Other Operating Expenses -43.39M-116.54M-913.33M93.75M53.01M-28.00M200.18M297.93M-238.03M143.63M272.32M190.29M105.71M305.06M924.67M118.80M241.23M277.14M-76.51M583.60M212.43M-227.60M164.04M-127.14M-111.40M12.90M
Operating Expenses 3.98M-68.22M-874.43M139.45M101.59M27.83M258.09M343.73M-189.99M282.72M422.28M342.33M158.16M381.25M1,048.40M205.00M289.36M384.87M-16.83M641.75M267.64M-170.38M232.13M34.06M368.87M182.13M
Operating Income 430.90M532.50M1,331.92M361.43M409.35M510.57M314.06M229.30M744.95M303.05M153.42M219.72M377.79M192.21M-482.65M478.97M248.84M151.44M612.90M-73.77M269.63M735.07M361.51M534.18M209.80M427.16M
EBIT 430.90M532.50M1,331.92M361.43M409.35M510.57M314.06M229.30M744.95M303.05M153.42M219.72M377.79M192.21M-482.65M478.97M248.84M151.44M612.90M-73.77M269.63M735.07M361.51M534.18M209.80M427.16M
Non-operating items
Non Operating Investment Income -25.84M-13.52M39.64M-33.45M0.65M-7.09M-2.19M-2.56M-1.91M-16.97M-0.10M71.81M25.79M-0.98M7.09M-0.70M-8.68M3.00M-9.00M-1.00M-2.00M4.00M
Interest & Investment Income 10.03M4.58M3.25M2.86M2.72M1.59M21.21M16.60M14.04M12.26M10.64M9.53M10.92M14.03M43.85M16.70M25.65M23.44M6.50M7.42M13.38M17.51M9.04M11.29M8.33M6.90M
Other Non Operating Income 0.06M0.23M0.14M-5.92M0.26M-23.34M-3.82M0.04M-0.11M-0.79M-4.82M-1.76M-1.03M-10.80M-1.17M-2.81M1.09M-1.71M-18.31M-3.69M6.00M-1.65M-2.19M-3.06M-1.54M-1.57M
Non Operating Income -34.81M-92.47M114.61M-252.33M192.63M113.69M52.57M-70.32M61.81M-81.26M-99.75M-91.64M113.81M28.20M-127.38M30.12M102.50M-29.36M104.69M69.50M-75.25M71.28M-27.16M-100.75M-119.16M17.05M
Net income details
EBT 396.09M440.03M1,446.53M109.10M601.98M624.25M366.63M158.98M806.75M221.80M53.67M128.08M491.60M220.41M-610.03M509.09M351.34M122.08M717.59M-4.27M194.38M806.36M334.35M433.43M90.64M444.21M
Profit After Tax 396.09M440.03M1,446.53M109.10M86.19M710.44M1,077.07M158.98M806.75M221.80M53.67M128.08M491.60M220.41M-610.03M509.09M351.34M122.08M717.59M4.78M194.38M806.36M334.35M433.43M90.64M444.21M
Equity Income 53.74M-8.04M177.46M-153.17M193.90M160.23M46.12M-54.19M55.49M-19.29M-66.60M-36.16M8.02M5.17M-10.47M34.61M41.27M-5.22M55.15M77.73M-47.12M50.85M-41.91M-45.88M-30.55M18.86M
Income from Non-Controlling Interests 28.65M31.05M26.13M37.86M159.90M333.62M195.53M89.86M365.98M119.87M45.77M76.32M187.09M77.76M-153.95M168.33M123.71M49.96M223.25M-9.05M92.37M262.37M126.14M195.08M60.46M155.99M
Income from Continuing Operations 396.09M440.03M1,446.53M109.10M601.98M624.25M366.63M158.98M806.75M221.80M53.67M128.08M491.60M220.41M-610.03M509.09M351.34M122.08M717.59M-4.27M194.38M806.36M334.35M433.43M90.64M444.21M
Consolidated Net Income 396.09M440.03M1,446.53M109.10M601.98M624.25M366.63M158.98M806.75M221.80M53.67M128.08M491.60M220.41M-610.03M509.09M351.34M122.08M717.59M-4.27M194.38M806.36M334.35M433.43M90.64M444.21M
Income towards Parent Company 396.09M440.03M1,446.53M109.10M601.98M624.25M366.63M158.98M806.75M221.80M53.67M128.08M491.60M220.41M-610.03M509.09M351.34M122.08M717.59M-4.27M194.38M806.36M334.35M433.43M90.64M444.21M
Net Income towards Common Stockholders 396.09M440.03M1,446.53M109.10M601.98M624.25M366.63M158.98M806.75M221.80M53.67M128.08M491.60M220.41M-610.03M509.09M351.34M122.08M717.59M-4.27M194.38M806.36M334.35M433.43M90.64M444.21M
Additional items
EPS (Basic) 2.430.180.990.790.440.181.080.240.090.120.700.32-1.040.760.510.161.110.010.231.220.470.550.070.67
EPS (Weighted Average and Diluted) 1.700.790.440.181.080.240.130.120.700.32-1.040.760.500.161.100.010.231.210.470.550.070.67
Shares Outstanding (Weighted Average) 595.38M595.38M607.11M607.11M607.11M607.11M607.11M607.17M607.17M607.18M607.18M607.22M607.22M607.22M601.82M601.82M597.43M597.44M597.44M593.46M589.18M576.45M562.24M583.17M
Shares Outstanding (Diluted Average) 353.98M370.00M375.45M607.15M607.16M607.17M414.80M607.20M607.21M607.23M437.97M607.25M606.55M604.72M602.90M597.48M597.20M595.68M594.11M578.10M570.16M566.75M
EBITDA 369.03M407.70M1,427.89M128.03M447.40M294.44M181.48M63.63M436.73M93.60M153.42M219.72M377.79M192.21M-482.65M478.97M248.84M151.44M612.90M-73.77M269.63M735.07M361.51M534.18M209.80M427.16M
Interest Expenses 67.27M68.80M63.34M53.58M34.19M31.44M37.84M37.41M37.43M44.33M46.97M47.06M46.97M46.98M46.95M46.95M46.95M46.03M47.26M44.23M49.01M66.51M65.76M65.26M68.67M79.56M